Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21724725.
- Also identified by DOI 10.3899/jrheum.110281.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The interstitial lung diseases (ILD) are a group of heterogeneous diseases that exert significant morbidity and mortality in connective tissue diseases (CTD). There is no consensus on measures of disease activity or therapeutic responsiveness, which hampers effective drug development and regulatory evaluation of candidate therapies. The CTD-ILD Special Interest Group represents an international multidisciplinary effort to identify consensus on criteria to measure disease activity and therapeutic response in CTD-ILD. We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings.
Medical subject headings
- Connective Tissue Diseases
- Lung Diseases, Interstitial
- Outcome Assessment, Health Care
- Severity of Illness Index